Bevacizumab Biosimilar Market Size, Share, Trends, and Forecast 2030

agregó una foto Health

2026-08-31 09:41:42 -

The Bevacizumab Biosimilar Market is witnessing steady expansion as pharmaceutical companies develop affordable alternatives to high-cost biologic cancer therapies. WiseGuyReports estimates that the market will increase from USD 2.35 billion in 2025 to USD 5 billion by 2035, growing at a CAGR of 7.8%. One of the primary trends influencing the market is the increasing acceptance of...

0 Commentarios 0 Acciones 2 Views 0 Vista previa